ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 579,73
-0,69%
Dow Jones
40 211,72
0,53%
DAX
18 498,64
-0,55%
Brent Oil
83,765
-0,68%
Bitcoin
63 172,28
-2,59%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
09/05/201614h40Dow Jones NewsTeva Revenue Declines as Some Drugs Lose ExclusivityNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201613h02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201613h00Business WireTeva Reports First Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201618h36PR Newswire (US)Teva Breathes Its Way to a Guinness World Records TitleNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201614h00Business WireTeva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/04/201614h00Business WireJennifer Morrison Reveals How Her Journey with Migraine is More Than a HeadacheNYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/201614h30Business WireTeva to Report First Quarter 2016 Financial Results on May 9, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/201614h00Business WireTeva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouv...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/04/201614h00Business WireTeva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
07/04/201615h00Dow Jones NewsAllergan Completes Licensing Deal After Pfizer Bid CollapsesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/04/201601h30Business WireTakeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in JapanNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201619h50Dow Jones NewsFTC Seeks More Information on Pfizer-Allergan MergerNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201615h55Business WireTeva Announces FDA Approval of CINQAIR® (reslizumab) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
22/03/201613h00Business WireTeva Announces Launch of Generic Campral® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/03/201617h10Dow Jones NewsTeva Acquisition of Allergan Generics Unit Delayed--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
15/03/201616h30Dow Jones NewsTeva Acquisition of Allergan Generics Unit DelayedNYSE:TEVATeva Pharmaceutical Industries Ltd
11/03/201617h30Business WireTeva to Present at the Barclays Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h13Dow Jones NewsEU Approves Teva Takeover of Allergan Generics Unit -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h10Dow Jones NewsEU Approves Teva Takeover of Allergan Generics UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201616h07Dow Jones NewsEU Approves Teva's Takeover of Allergan's Generics UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
10/03/201615h02Business WireTeva Receives European Commission Approval for the Allergan Generics AcquisitionNYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201621h54Dow Jones NewsTeva Deal for Allergan Generics Unit Expected to Get Europe OK -ReutersNYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201619h00Business WireTeva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/03/201617h33Business WireTeva Completes Generic Pulmicort® Respules Portfolio with the Launch of Third Strength in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
03/03/201615h10Business WireTeva Completes Acquisition of RimsaNYSE:TEVATeva Pharmaceutical Industries Ltd
03/03/201614h00Business WireTeva to Present New Respiratory Data at the 2016 Academy of Allergy, Asthma and Immunology Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201617h07Business WireTeva to Present at the Cowen & Company 36th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201615h00PR Newswire (Canada)Teva Canada Announces the Launch of (Pr)Teva-Tobramycin Inhalation Solution, a Generic of (Pr)Tobi®NYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201615h00PR Newswire (Canada)Teva Canada annonce le lancement de la solution pour inhalation (Pr)Teva-Tobramycin, un substitut générique de (Pr)Tobi®NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201612h00Business WireTeva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global BrandNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
NKE
Nike
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
EU
CAP
Capgemini
NYSE
MCD
McDonalds
EU
EN
Bouygues
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés